Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 22679 matches for

Oxford becomes the first British university ever to occupy top position in the global table, which judges the performance of 980 universities across 79 countries.

Radcliff Camera and All Souls College buildings

Francois Nosten on Fever Pitch podcast, on a collapsing border where medicine meets war

Professor Francois Nosten, Director of MORU's Shoklo Malaria Research Unit (SMRU), reflects on the decades he’s spent on the border between Thailand and Myanmar, a place of relentless upheaval and quiet endurance. From the 1980s onward, he has lived amid war, displacement, and disease, building a fragile bridge between science and survival. He characterizes the border as a wound that never quite closes – people cross not for opportunity but to escape a state that devours its own. What he describes is not steady progress but a cycle of collapse and recovery, every advance shadowed by the return of violence and the onset of disease.

Professor Nicholas Day Honoured for Services to Global Health

Professor Nicholas Day has been appointed Companion of the Order of St Michael and St George (CMG) for his outstanding contributions to global health research in the Kings New Years Honours 2026. With a career spanning over three decades at OUCRU and MORU, his leadership in infectious disease research has significantly advanced health equity in low-resource settings.

SMRU’s ‘TB Village’: A lifeline for marginalised patients on the Thai–Myanmar border

In a settlement of bamboo cabins, among mango and jackfruit trees, the Shoklo Malaria Research Unit runs a secluded clinic known as 'TB Village.' Reachable only by dirt roads, this sanctuary provides critical treatment and quarantine for dozens of marginalized Burmese tuberculosis patients. Here, at SMRU, patients receive care for diseases like tuberculosis and malaria. The unit works to heal patients and prevent outbreaks from crossing borders, providing a lifeline of safety.

Oxford-led researchers develop a low-cost rapid test to identify heat-damaged vaccines

Researchers from Medicine Quality Research Group, the University of Oxford and their collaborators have developed and evaluated a novel low-cost, rapid method to identify heat-exposed sucrose-containing vaccines without the need for sophisticated laboratory equipment.

Research Spotlight: The IRONMUM Trial at SMRU

IRONMUM is one example of SMRU’s long-standing collaboration with global partners to address critical health challenges in low- and middle-income settings. Through partnerships with institutions such as the University of Oxford and the Mahidol Oxford Tropical Medicine Research Unit (MORU), SMRU conducts research that is firmly grounded in local realities, ensuring that preventive strategies and treatments are effective where they are needed most. Working on the Thailand–Myanmar border since 1986, SMRU combines research, clinical care, and humanitarian action to improve the health of mothers, children, and vulnerable populations affected by infectious diseases and limited access to healthcare.

International collaboration launches largest-ever therapeutics trial for patients hospitalised with dengue

A landmark international research collaboration has launched the largest clinical trial ever conducted to test therapeutics for moderate-severe dengue, a mosquito-borne viral disease that continues to spread rapidly driven by climate change and globalisation.

Global Consortium Launched to Develop Next-Generation Malaria Vaccine

A new international consortium, MVC-2G, has been launched to develop a next-generation malaria vaccine offering broader protection by targeting multiple stages of the parasite’s lifecycle. Co-led by KWTRP and supported by African, UK and EU partners, the five-year effort aims to improve vaccine efficacy. KWTRP is committed to producing rigorous clinical evidence to ensure new tools meet the needs of African communities most affected by malaria, supporting regional vaccine research, delivery, and long-term impact.

Blood test predicts risk of death in acutely ill children in lower-income countries

An international study has identified a blood-based indicator of intestinal damage and inflammation that strongly predicts mortality in sick children. The new biomarker could help to identify those children at greatest risk of dying after hospitalisation in parts of the world with limited resources.

OUCRU trials AI-powered wearables for early warning of severe dengue

AI applications in dengue monitoring and prediction are showing encouraging early signals, with new models achieving around 80% accuracy in forecasting severe progression up to two hours in advance. The Oxford University Clinical Research Unit (OUCRU) presented these findings at the Dengue Summit 2025, organised by Ho Chi Minh City Pasteur Institute.

Avoidable pitfalls on the path to health financing self-reliance in low-income and middle-income countries

Low- and middle-income countries (LMICs) are facing an urgent and complex challenge: how to transition to greater self-sustainability in health financing amid declining donor support. While this shift is inevitable, the policy responses it elicits carry significant implications for health system equity and access.

Rapid, low-cost tests can help prevent child deaths from contaminated medicinal syrups

Researchers at the University of Oxford and their collaborators have demonstrated that simple, rapid, and inexpensive tests can detect deadly contaminants in medicinal syrups - contaminants that have tragically led to the deaths of hundreds of children worldwide.

Community Engagement in Antimicrobial Stewardship Programmes Implementation – 60HN ASPARNet

The study titled “Evaluating Antimicrobial Stewardship strategies and capacity building through Participatory Action Research and a Network approach in Vietnam” (60HN – ASPARNet) continues to implement activities to promote Antimicrobial Stewardship (AMS) programmes across hospitals participating in the network.

Data platform will play a vital role in future VL research

A new publication authored by IDDO’s Visceral Leishmaniasis (VL) Scientific Advisory Committee sets out a research agenda for VL, and describes how IDDO established and developed a data platform that enables data reuse for crucial historical data.

‘Creeping catastrophe’: Climate change is driving global rise in infectious diseases, leading health experts warn

Infectious diseases such as malaria, dengue, and tuberculosis are considered to pose as great a challenge to global health as new or emerging pathogens, according to a major international study led by The Global Health Network at Oxford’s Nuffield Department of Medicine and commissioned by Wellcome.

Youth Peer Educator Combat AMR: Indonesian Youth Action in Antimicrobial Resistance’s Stewardship

Knowledge and beliefs about antibiotics continue to shape emerging health behaviours in Indonesia. With support from OUCRU, PAPRA empowered young people to create learning resources to promote responsible antibiotic use among their peers.

Shaping Oxford’s Vision for Global Health in a Period of Turbulence

The first Oxford Global Health Summit united colleagues across the University to drive a bold, collaborative vision for global health.

Oxford Global Health welcomes Ghana’s High Commissioner for engagement on malaria and strengthening collaboration

Oxford Global Health welcomed Ghana’s High Commissioner and her delegation for a day of discussions on malaria elimination and future collaboration.

Optimizing Newborn Care: Inside the NeoSep1 trial

Neonatal sepsis, worsened by antimicrobial resistance (AMR), remains a major cause of infant deaths in Africa. The NeoSep1 Trial, led by GARDP and KEMRI, is testing tailored antibiotic combinations for newborns. This research aims to update WHO guidelines, strengthen local research capacity, and improve access to effective treatments across low-resource settings.

Analysis of SMRU samples could lead to vaccine for multiple childhood infections

The first large-scale genomic exploration of H. influenzae, a bacteria that causes 200m infections per year in children worldwide, has revealed extensive antibiotic resistance and uncovered genetic clues that could help in future vaccine development, say researchers from Wellcome Sanger Institute, the Universities of Oxford and Oslo, and MORU’s Shoklo Malaria Research Unit (SMRU) and Cambodia-Oxford Medical Research Unit (COMRU).

Rose McGready honoured for her work to improve healthcare for Thai-Myanmar border communities

On 17 Nov at a ceremony in Canberra, Prof Rose McGready, Deputy Director of the Shoklo Malaria Research Unit (SMRU), was honoured with the 2026 ACT Australian of the Year Award for her extraordinary dedication over 30 years to improving healthcare for displaced and marginalised communities along the Thai-Myanmar border which, coupled with clinical and research work that has changed the treatment of malaria around the world, particularly for pregnant and breastfeeding women, has saved the lives of countless mothers and their babies.

Load More

Similar stories